tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Centessa falls -9.9%
PremiumThe FlyCentessa falls -9.9%
28d ago
Centessa Pharmaceuticals: Promising Orexin Agonist Platform Justifies Buy Rating
Premium
Ratings
Centessa Pharmaceuticals: Promising Orexin Agonist Platform Justifies Buy Rating
28d ago
Centessa initiated with an Outperform at LifeSci Capital
Premium
The Fly
Centessa initiated with an Outperform at LifeSci Capital
28d ago
Centessa Pharmaceuticals: Buy Rating Driven by ORX750’s Promising Efficacy and Acquisition Potential
PremiumRatingsCentessa Pharmaceuticals: Buy Rating Driven by ORX750’s Promising Efficacy and Acquisition Potential
2M ago
Centessa Pharmaceuticals: Promising Pipeline Developments and Strategic Flexibility Drive Buy Rating
Premium
Ratings
Centessa Pharmaceuticals: Promising Pipeline Developments and Strategic Flexibility Drive Buy Rating
2M ago
Centessa Pharmaceuticals Advances Orexin Agonist Pipeline
Premium
Company Announcements
Centessa Pharmaceuticals Advances Orexin Agonist Pipeline
2M ago
Positive Market Outlook for Centessa Pharmaceuticals Driven by Promising Developments in Orexin Agonist Class
PremiumRatingsPositive Market Outlook for Centessa Pharmaceuticals Driven by Promising Developments in Orexin Agonist Class
3M ago
Optimistic Buy Rating for Centessa Pharmaceuticals Driven by Orexin Agonist Market Potential and Positive Safety Profile
Premium
Ratings
Optimistic Buy Rating for Centessa Pharmaceuticals Driven by Orexin Agonist Market Potential and Positive Safety Profile
3M ago
Centessa Pharmaceuticals Positioned for Leadership in Orexin Agonist Market with Promising ORX750 Candidate
Premium
Ratings
Centessa Pharmaceuticals Positioned for Leadership in Orexin Agonist Market with Promising ORX750 Candidate
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100